Pipeline

Hummingbird Bioscience Programs Target Class Indication Discovery Pre-Clinical Phase 1 Clinical Proof of Concept
HMBD-001
Learn More
NCT05057013
HER3 mAb Multiple Solid Tumors
90% Complete
HMBD-002
Learn More
NCT05082610
VISTA mAb Multiple Solid Tumors
90% Complete
HMBD-501
HER3 ADC Multiple Solid Tumors
30% Complete
HMBD-009
Learn More
BCMA-TACI (dual-specific) Bispecific under evaluation Multiple Myeloma
50% Complete
HMBD-011 VH4-34 mAb Oncology & Autoimmune
30% Complete
HMBD Discovery Multiple Undisclosed Undisclosed Undisclosed
10% Complete
Amgen Collaboration Multiple Undisclosed Undisclosed Undisclosed
10% Complete